Biomarker Strategies for Cell Therapy in Autoimmune Diseases Measuring the B Cell Reset

Home > Science Hub > Biomarker Strategies for Cell Therapy in Autoimmune Diseases Measuring the B Cell Reset
Back to the list

October 16, 2024

You might also be interested by

CellTalk Blog

Rescuing a Pilot Study: How a Coordinated Response From CellCarta Kept a Critical Program on Track

April 14, 2026

More info

CellTalk Blog

Emerging Biomarkers Shaping the Next Generation of ADC Therapies

April 14, 2026

More info

CellTalk Blog

Meeting a Critical Deadline: How CellCarta’s California Laboratory Team Accelerated Assay Development and Clinical Testing to Deliver Ahead of Schedule

April 14, 2026

More info

Press Releases

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials

April 7, 2026

More info